2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow CIS43LS: new trials by email Literature Review of CIS43LS trials Research Report on CIS43LS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali VRC-MALMAB0100-00-AB (CIS43LS), Normal saline - Plasmodium Falciparum Infection, Malaria | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 348 | 2021-02-15 | 2025-04-09 |
| Trial to Evaluate CIS43LS in Healthy Adults VRC-MALMAB0100-00-AB, Plasmodium falciparum (P. falciparum) sporozoite challenge - Malaria | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 71 | 2020-01-07 | 2023-04-18 |
Malaria (2) · Parasitemia (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2)
Mali (1) · United States (1)
Kassoum Kayentao, MD, MPH, PhD (1) · Peter D. Crompton, MD, MPH (1)
PMID 34379916, PMID 36317783, PMID 36708738, PMID 40461818, PMID 42407014